RxGenomix, and Translational Software (TSI), today announced a partnership that increases the value of their individual offerings and makes it easier for a wide range of employers, payors, and healthcare providers to implement pharmacogenomics as a compelling component of their clinical and benefits strategies.
May 12, 2020
· 4 min read